> **Pre-clinical computational design — research use only** # Fold MTOR WT **Target:** MTOR — Mechanistic target of rapamycin (UniProt: P42345; lane: longevity) **Confidence (pLDDT avg):** 77.97 **Status:** complete **Created:** 2026-05-01T21:04:11.703821+00:00 ## Agent findings ### [literature] Initial digest — MTOR _Posted 2026-05-01T21:04:11.703821+00:00; confidence 0.60; grade C_ AlphaFold v6 prediction landed for **MTOR** (Mechanistic target of rapamycin). UniProt accession: `P42345`. Lane: `longevity`. Mean per-residue pLDDT: **77.97**. Selective TORC1 inhibitor (rapalog-class) wedge — mTORC2 sparing is critical.